Apollo-managed funds have agreed to acquire a 37% minority stake in Syntegon from CVC Capital Partners, as the private equity firms partner to accelerate the company’s next phase of growth.

CVC will retain a 63% majority stake in the business, reaffirming its long-term commitment following a multi-year transformation of the industrial technology platform.

The transaction marks a continuation of Syntegon’s growth strategy, supported by strong operational performance and expanding end-market demand.

The company generated €1.75bn in revenue in 2025, with operating profit having quadrupled since CVC’s investment, highlighting significant value creation under private equity ownership.

“Bringing on board a minority shareholder offers the best conditions to further accelerate Syntegon’s growth globally,” said Marc Strobel, Partner at CVC.

Apollo’s investment is expected to provide additional expertise, particularly in advancing Syntegon’s expansion in North America, while supporting further operational scaling.

“Together with CVC and management, we see a clear path to continue this strong growth trajectory,” said Jeremy Honeth, Partner at Apollo.

Syntegon operates across the pharmaceutical, biotechnology, and food industries, with approximately 72,000 installed systems worldwide, offering a significant service opportunity.

The partnership reflects a growing trend of private equity firms bringing in strategic co-investors to support international expansion and unlock further value.

The transaction remains subject to customary regulatory approvals.

If you think we missed any important news, please do not hesitate to contact us at [email protected].